13 results about "Dietary supplementation" patented technology

This invention relates to the field of biotechnology, and more particularly to a swelling-promoting seahorse oil and its application in the preparation of anti-sarcopenia products. Obtained using a supercritical carbon dioxide extraction process, the swelling-promoting seahorse oil of this invention has been experimentally verified to inhibit muscle degradation, promote muscle cell activation and differentiation, increase muscle mass, and enhance muscle strength and endurance. Furthermore, it exerts its effects through dietary supplementation with no significant adverse reactions, and can be used to prepare anti-sarcopenia related foods, health products, or pharmaceuticals to meet the muscle health maintenance needs of the elderly.

This invention belongs to the field of pharmaceutical technology, specifically relating to an alginate oligosaccharide, its preparation method, and its applications. Using brown algae as raw material, the invention first removes impurities from the algae, then extracts it through subcritical acid water, followed by neutralization, decolorization, heavy metal removal, membrane ultrafiltration / nanofiltration purification, and spray drying to obtain high-purity saturated alginate oligosaccharides with a specific degree of polymerization distribution. These alginate oligosaccharides can increase butyrate production by intestinal flora and exert a laxative effect. The alginate oligosaccharide and its preparation method provided by this invention directly use brown algae as raw material, overcoming the drawbacks of traditional methods that first prepare alginate and then hydrolyze it to prepare alginate oligosaccharides, greatly shortening the process steps and improving production efficiency. The alginate oligosaccharides provided by this invention have high purity and broad application potential in the preparation of intestinal health drugs, health products, or dietary supplements.

The present invention relates to the use of riboprine in the maintenance, improvement, or dietary management of gut barrier function. The riboprine may be formulated in an oral composition such as dietary supplement, a food product, a food for special medical purpose (FSMP) or a food for special dietary use (FSDU).

Methods are provided for treating and diagnosing diseases and disorders associated with retinal degeneration, such as retinitis pigmentosa. Dietary supplementation with specific metabolites and vitamins can prolong vision and provide a neuroprotective effect. In particular, dietary supplementation with a-ketoglutarate, or a derivative thereof, significantly prolongs photoreceptor cell survival and visual function. In addition, dietary supplementation with B vitamins and a ketogenic diet also improves photoreceptor cell survival and delays disease progression in some cases. Additionally, compositions, methods, and kits are provided for diagnosing a subject with retinitis pigmentosa based on expression levels of vitreous biomarkers.

This invention discloses a regulatory dietary supplement containing mulberry leaf γ-aminobutyric acid (GABA) and polyphenols, and its preparation method, belonging to the field of dietary food technology. It consists of the following raw materials in parts by weight: 15-30 parts mulberry leaf extract, 40-60 parts cereal base, 10-20 parts plant protein powder, 5-15 parts dietary fiber, 2-8 parts mineral fortifier, and 1-5 parts natural sweetener; the mulberry leaf extract contains ≥8 mg / g GABA and ≥15 mg / g total polyphenols; the mineral fortifier is potassium salt, with a sodium content ≤120 mg / 100g and a potassium content ≥500 mg / 100g. The preparation method includes: compound enzymatic hydrolysis-ultrasonic synergistic extraction of mulberry leaf extract, low-temperature drying and pulverization of barley grass powder, premixing and masking the flavor of the mineral fortifier and protein powder, and total granulation. This invention utilizes the synergistic effect of GABA and polyphenols on the neurovascular dual pathway, providing dual functions of soothing emotions and assisting in blood pressure regulation. It is also low in sodium and high in potassium, with an excellent taste, making it suitable for daily dietary supplementation and functional meal replacement for people who value a healthy lifestyle and those with special nutritional needs.

A core four dietary supplement system comprising at least one collagen system, at least one microdaily EMF system, at least one omega-3 system and at least one prebiotic and probiotic system with acid and heat resistant bacteria, is provided.

Methane production in ruminants can be reduced by improving rumen fermentation efficiency through dietary supplementation with Asparagopsis taxiformis. This disclosure relates to a method for producing A. taxiformis and its use. In a specific form, this disclosure relates to a method for producing tetrasporophytes and gametophytes of A. taxiformis by environmental manipulation.

The invention relates to the technical field of biology, in particular to belly-distending hippocampus oil and application thereof in preparation of sarcopenia-resistant products. The swelling sea horse oil is obtained by adopting a supercritical carbon dioxide extraction process, and experiments prove that the swelling sea horse oil can inhibit muscle degradation, promote muscle cell activation and differentiation and increase muscle weight, muscle strength and endurance; the composition can play a role in a dietary supplement mode, has no obvious adverse reaction, can be used for preparing anti-sarcopenia related food, health care products or medicines, and meets the requirements of old people for muscle health maintenance.

The present disclosure relates to a bioflavonoid composition comprising a bioflavonoid, at least one surfactant with a molecular weight between 300 and 1500 g / mol, and optionally a macromeric compound. The composition exhibits enhanced solubility and bioavailability and may be formulated into various delivery formats, including hard gelatin capsules and nutraceutical food products. The present disclosure also relates to a process for preparing the composition involves mixing the bioflavonoid with optional polysaccharides and suspending agents, followed by the addition of an aqueous surfactant and binder solution. The composition of the present disclosure is suitable for use in dietary supplements or medicaments and may be administered to manage various health conditions or disorders.

Methane production in ruminant animals may be reduced by improving rumen fermentation efficiency through dietary supplementation of Asparagopsis taxiformis. The present disclosure relates to a method of producing A. taxiformis and uses thereof. In particular forms, the present disclosure relates to methods of producing a tetrasporophyte and a gametophyte of A. taxiformis through environmental manipulations.

The invention belongs to the technical field of biology, and particularly relates to selenium-containing yolk immunoglobulin with neuroprotection activity and a preparation method and application thereof, and the selenium-containing yolk immunoglobulin contains organic selenium selenocysteine and / or organic selenium selenomethionine. The invention provides selenium-containing egg yolk immunoglobulin and a preparation method thereof, the selenium-containing egg yolk immunoglobulin is screened from selenium-rich egg yolk, the selenium-containing egg yolk immunoglobulin contains selenium, contains organic selenium selenocysteine and selenomethionine, does not contain inorganic selenium and has neuroprotective activity, a secondary structure of the selenium-containing egg yolk immunoglobulin mainly adopts beta folding, and the secondary structure of the selenium-containing egg yolk immunoglobulin mainly adopts beta folding. The protein extract plays a protection role by reducing the NO content and ROS content of BV-2 cells and increasing the GPx content, the SOD content and the CAT content. The selenium-containing yolk immunoglobulin provided by the invention is from food sources, is safe and low-sensitive, and has good neuroprotective activity, a high dose of peptide is suitable for patients with moderate and severe diabetes, and a low dose of peptide is suitable for daily diet supplement of the patients with diabetes in an early stage or a stable stage.

Pharmaceutical, nutritional, and nutraceutical formulation, and manufacturing process for the treatment and nutrition of individuals with diabetes. This patent relates to a pharmaceutical and nutritional invention for a pharmaceutical, nutraceutical, and nutritional formulation for the treatment and dietary supplementation of individuals with diabetes, as well as the preparation method for both. The pharmaceutical formulation is composed of seed extracts from the species jambolão (Syzygium cumini L), of the Myrtaceae family, and quixaba (Sideroxylon obtusifolium), of the Sapotaceae family. The nutritional formulation is composed of jambolão seed powder and quixaba seed powder. the present invention is in the fields of pharmacy and nutrition, notably where they can be produced for human use in the following pharmaceutical, nutraceutical and food forms: capsules, tablets and solutions, microgranules, nanocapsules, pellets, syrups, suspensions, emulsions, and can also be incorporated into various foods such as cereal bars, biscuits, flours, shakes, among others, not being limited to these food forms presented, but becoming in itself a food fortification agent.

This invention relates to the field of biomedical technology, specifically to the application of L-methionine in the preparation of drugs for preventing and treating cognitive impairment in offspring. According to this invention, early intervention through maternal dietary supplementation with L-methionine following heavy metal exposure can provide long-term and comprehensive improvement in offspring's cognitive recognition, spatial memory, and adventurous exploration behaviors, without significantly affecting maternal cognitive behavior. This invention is the first to clearly define pregnancy as a critical window for L-methionine intervention in offspring cognitive impairment caused by heavy metal exposure, providing a safe, feasible, and scientifically based nutritional intervention strategy, and offering a new approach for related public health prevention and product development.